A detailed history of Sepio Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Sepio Capital, LP holds 288 shares of LLY stock, worth $214,905. This represents 0.02% of its overall portfolio holdings.

Number of Shares
288
Holding current value
$214,905
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $222,376 - $276,485
288 New
288 $255,000
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $262,595 - $309,565
500 New
500 $291,000
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $41,479 - $48,332
-129 Reduced 18.51%
568 $207,000
Q3 2022

Oct 28, 2022

BUY
$296.48 - $337.87 $11,859 - $13,514
40 Added 6.09%
697 $228,000
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $183,125 - $215,016
657 New
657 $213,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sepio Capital, LP Portfolio

Follow Sepio Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.